197 related articles for article (PubMed ID: 21203549)
21. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
22. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
23. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.
Gao Q; Zhao YJ; Wang XY; Qiu SJ; Shi YH; Sun J; Yi Y; Shi JY; Shi GM; Ding ZB; Xiao YS; Zhao ZH; Zhou J; He XH; Fan J
Cancer Res; 2012 Jul; 72(14):3546-56. PubMed ID: 22710437
[TBL] [Abstract][Full Text] [Related]
24. ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells.
Wee B; Pietras A; Ozawa T; Bazzoli E; Podlaha O; Antczak C; Westermark B; Nelander S; Uhrbom L; Forsberg-Nilsson K; Djaballah H; Michor F; Holland EC
Sci Rep; 2016 Jul; 6():25956. PubMed ID: 27456282
[TBL] [Abstract][Full Text] [Related]
25. The CXCL16-CXCR6 chemokine axis in glial tumors.
Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
[TBL] [Abstract][Full Text] [Related]
26. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
[TBL] [Abstract][Full Text] [Related]
27. Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996.
Li XX; Wang J; Wang HL; Wang W; Yin XB; Li QW; Chen YY; Yi J
Biochem Biophys Res Commun; 2012 Mar; 419(4):728-34. PubMed ID: 22387537
[TBL] [Abstract][Full Text] [Related]
28. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
[TBL] [Abstract][Full Text] [Related]
29. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma.
Seidl H; Richtig E; Tilz H; Stefan M; Schmidbauer U; Asslaber M; Zatloukal K; Herlyn M; Schaider H
Hum Pathol; 2007 May; 38(5):768-80. PubMed ID: 17306330
[TBL] [Abstract][Full Text] [Related]
30. Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.
Dou J; Jiang C; Wang J; Zhang X; Zhao F; Hu W; He X; Li X; Zou D; Gu N
Cell Biol Int; 2011 Mar; 35(3):227-34. PubMed ID: 21108606
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
32. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
[TBL] [Abstract][Full Text] [Related]
33. Evaluating stem and cancerous biomarkers in CD15+CD44+ KYSE30 cells.
Rassouli FB; Matin MM; Bahrami AR; Ghaffarzadegan K; Cheshomi H; Lari S; Memar B; Kan MS
Tumour Biol; 2013 Oct; 34(5):2909-20. PubMed ID: 23797812
[TBL] [Abstract][Full Text] [Related]
34. ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD.
Kawai N; Hirohashi Y; Ebihara Y; Saito T; Murai A; Saito T; Shirosaki T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Shichinohe T; Li L; Hirano S; Torigoe T
PLoS One; 2019; 14(5):e0216503. PubMed ID: 31083682
[TBL] [Abstract][Full Text] [Related]
35. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
[TBL] [Abstract][Full Text] [Related]
36. Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?
Brinckerhoff CE
J Cell Physiol; 2017 Oct; 232(10):2674-2678. PubMed ID: 28078710
[TBL] [Abstract][Full Text] [Related]
37. Finding the root of the problem: the quest to identify melanoma stem cells.
Abel EV; Aplin AE
Front Biosci (Schol Ed); 2011 Jun; 3(3):937-45. PubMed ID: 21622243
[TBL] [Abstract][Full Text] [Related]
38. Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.
Miranda-Lorenzo I; Dorado J; Lonardo E; Alcala S; Serrano AG; Clausell-Tormos J; Cioffi M; Megias D; Zagorac S; Balic A; Hidalgo M; Erkan M; Kleeff J; Scarpa A; Sainz B; Heeschen C
Nat Methods; 2014 Nov; 11(11):1161-9. PubMed ID: 25262208
[TBL] [Abstract][Full Text] [Related]
39. CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes.
Fallahi P; Corrado A; Di Domenicantonio A; Frenzilli G; Antonelli A; Ferrari SM
Curr Drug Targets; 2016; 17(5):515-9. PubMed ID: 25547908
[TBL] [Abstract][Full Text] [Related]
40. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]